Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 52,987 | 50,959 | 49,854 | 44,939 | 39,725 |
| Gross Profit | 52,987 | 50,959 | 49,854 | 44,939 | 39,725 |
| Operating Expenses | 25,144 | 23,111 | 20,268 | 18,893 | 15,363 |
| Operating Income | 27,843 | 27,848 | 29,586 | 26,046 | 24,362 |
| Interest Expense | 8,955 | 8,404 | 9,361 | 7,179 | 6,320 |
| Other Income | 1 | -1,105 | 1 | 1 | 2 |
| Pre-tax Income | 18,889 | 18,339 | 20,226 | 18,868 | 18,044 |
| Income Tax | 1,958 | 2,272 | 2,815 | 2,102 | 2,396 |
| Net Income Continuous | 16,931 | 16,067 | 17,411 | 16,766 | 15,648 |
| Minority Interests | 0 | 0 | 0 | 238 | 513 |
| Net Income | $16,931 | $16,067 | $17,411 | $16,528 | $15,135 |
| EPS Basic Total Ops | 0.76 | 0.73 | 0.87 | 0.86 | 0.78 |
| EPS Basic Continuous Ops | 0.76 | 0.73 | 0.87 | 0.87 | 0.81 |
| EPS Diluted Total Ops | 0.75 | 0.71 | 0.84 | 0.84 | 0.77 |
| EPS Diluted Continuous Ops | 0.75 | 0.71 | 0.85 | 0.85 | 0.79 |
| EBITDA(a) | $45,192 | $45,232 | $44,847 | $39,568 | $36,347 |